283 related articles for article (PubMed ID: 25465164)
41. Management of steroid-sensitive nephrotic syndrome in children with type 1 diabetes.
Goldman M; Hébert D; Geary DF
Pediatr Nephrol; 2002 May; 17(5):351-4. PubMed ID: 12042892
[TBL] [Abstract][Full Text] [Related]
42. Cyclosporine in idiopathic nephrotic syndrome.
Ponticelli C
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
[TBL] [Abstract][Full Text] [Related]
43. Predictors of Relapse in Adult-Onset Nephrotic Minimal Change Disease.
Lee H; Yoo KD; Oh YK; Kim DK; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Lim CS
Medicine (Baltimore); 2016 Mar; 95(12):e3179. PubMed ID: 27015208
[TBL] [Abstract][Full Text] [Related]
44. Treatment patterns and steroid dose for adult minimal change disease relapses: A retrospective cohort study.
Ozeki T; Ando M; Yamaguchi M; Katsuno T; Kato S; Yasuda Y; Tsuboi N; Maruyama S
PLoS One; 2018; 13(6):e0199228. PubMed ID: 29912938
[TBL] [Abstract][Full Text] [Related]
45. Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: a control biopsy study.
Clasen W; Kindler J; Mihatsch MJ; Sieberth HG
Nephrol Dial Transplant; 1988; 3(6):733-7. PubMed ID: 3147414
[TBL] [Abstract][Full Text] [Related]
46. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
Kurathong P; Jesdapatarakul S
J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
[TBL] [Abstract][Full Text] [Related]
47. Adult-onset minimal change disease among Taiwanese: clinical features, therapeutic response, and prognosis.
Huang JJ; Hsu SC; Chen FF; Sung JM; Tseng CC; Wang MC
Am J Nephrol; 2001; 21(1):28-34. PubMed ID: 11275629
[TBL] [Abstract][Full Text] [Related]
48. Paucity of minimal-change lesion in children with early frequently relapsing steroid-responsive nephrotic syndrome.
Trachtman H; Carroll F; Phadke K; Khawar M; Nicastri A; Chen CK; Tejani A
Am J Nephrol; 1987; 7(1):13-7. PubMed ID: 3578368
[TBL] [Abstract][Full Text] [Related]
49. [Relapsing nephrotic syndrome in a diabetic patient with minimal change].
García Donaire JA; Manzanera MI; Valentín MO; Espejo B; Gutiérrez Martínez E; Praga M
Nefrologia; 2004; 24(2):179-82. PubMed ID: 15219093
[TBL] [Abstract][Full Text] [Related]
50. Long-term outcomes of persistent disease and relapse in primary membranous nephropathy.
Kanigicherla DA; Short CD; Roberts SA; Hamilton P; Nikam M; Harris S; Brenchley PE; Venning MC
Nephrol Dial Transplant; 2016 Dec; 31(12):2108-2114. PubMed ID: 26769682
[TBL] [Abstract][Full Text] [Related]
51. Incidence of nephrotic syndrome in patients with glomerulonephritis.
Sonkodi S; Tichy B; Mágori A; Ormos J
Acta Med Hung; 1986; 43(3):311-3. PubMed ID: 3588169
[TBL] [Abstract][Full Text] [Related]
52. Spontaneous remission of therapy-resistant minimal change nephritis in an adult woman 12 years after onset of the disease.
Raml A; Sedlak M; Schmekal B; Stuby U; Syre' G; Biesenbach G
Wien Med Wochenschr; 2006 Jul; 156(13-14):421-5. PubMed ID: 16937046
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathological features and outcome of secondary steroid resistant nephrotic syndrome: A retrospective analysis.
Qaiser H; Bajeer I; Khatri S; Hashmi S; Lanewala AA
J Pak Med Assoc; 2024 Mar; 74(3):524-527. PubMed ID: 38591291
[TBL] [Abstract][Full Text] [Related]
54. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
Kashtan C; Melvin T; Kim Y
Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
[TBL] [Abstract][Full Text] [Related]
55. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
Mitwalli AH; Hayat A; Alwakeel J; Hammad D
Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
[TBL] [Abstract][Full Text] [Related]
56. Long-term effects of steroid treatment on nephrotic syndrome associated with Kimura's disease and a review of the literature.
Matsuda O; Makiguchi K; Ishibashi K; Chida Y; Ida T; Matsuda K; Tomita K; Marumo F; Hiruma M
Clin Nephrol; 1992 Mar; 37(3):119-23. PubMed ID: 1563115
[TBL] [Abstract][Full Text] [Related]
57. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
[TBL] [Abstract][Full Text] [Related]
58. Pathological patterns of primary nephrotic syndrome in Central China: a retrospective study of 627 cases.
Chu F; Chen G; Liu Y
Ren Fail; 2014 May; 36(4):514-9. PubMed ID: 24564431
[TBL] [Abstract][Full Text] [Related]
59. Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature.
Karras A; de Montpreville V; Fakhouri F; Grünfeld JP; Lesavre P;
Nephrol Dial Transplant; 2005 Jun; 20(6):1075-82. PubMed ID: 15788438
[TBL] [Abstract][Full Text] [Related]
60. Childhood idiopathic steroid resistant nephrotic syndrome in Southwestern Nigeria.
Olowu WA; Adelusola KA; Adefehinti O
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):979-90. PubMed ID: 20814150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
